LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

LLY

729.83

-1.21%↓

JNJ

175.39

-0.94%↓

ABBV

206.2

-1.33%↓

UNH

301.19

-0.76%↓

AZN

79.85

-0.15%↓

Search

DarioHealth Corp

Atvērts

9.97 2,021.28

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.47

Max

10.81

Galvenie mērījumi

By Trading Economics

Ienākumi

-3.8M

-13M

Pārdošana

-1.4M

5.4M

Peļņas marža

-241.944

Darbinieki

196

EBITDA

209K

-9.2M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+93.75% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

5.5M

25M

Iepriekšējā atvēršanas cena

-2011.31

Iepriekšējā slēgšanas cena

9.97

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bearish Evidence

DarioHealth Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 27. aug. 22:51 UTC

Peļņas

Wesfarmers Plans Special Payout to Shareholders as Annual Net Profit Rises 14%

2025. g. 27. aug. 23:57 UTC

Peļņas

Trip.com Group 1H Rev $4.01B

2025. g. 27. aug. 23:57 UTC

Peļņas

Trip.com Group 1H Adj EPS $1.84

2025. g. 27. aug. 23:57 UTC

Peļņas

Trip.com Group 1H EPS $1.82

2025. g. 27. aug. 23:50 UTC

Tirgus saruna

Nikkei May Decline Amid Caution Over Tariff Impact, Chip Demand -- Market Talk

2025. g. 27. aug. 23:39 UTC

Peļņas

Correction to Nvidia Earnings Article -- WSJ

2025. g. 27. aug. 22:59 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 27. aug. 22:59 UTC

Tirgus saruna

HP CEO Sees Strong Back-to-School Spending on PCs -- Market Talk

2025. g. 27. aug. 22:58 UTC

Peļņas

South32 Records Significant Items of $71 Million Tied to Worsley, Mozal

2025. g. 27. aug. 22:57 UTC

Peļņas

South32 FY Free Cash Flow $192 Million

2025. g. 27. aug. 22:56 UTC

Peļņas

South32 FY Total Capital Expenditure $1.35 Billion

2025. g. 27. aug. 22:56 UTC

Peļņas

South32 FY Capital Expenditure $963 Million, Excluding EAIs

2025. g. 27. aug. 22:55 UTC

Peļņas

South32 Net Cash $123 Million at June 30

2025. g. 27. aug. 22:54 UTC

Peļņas

South32: Focused on Maintaining Strong Operating Momentum

2025. g. 27. aug. 22:53 UTC

Peļņas

South32: $144 Million Remains to be Returned to Shareholders Under Program

2025. g. 27. aug. 22:53 UTC

Peļņas

South32 Extends Capital Management Program for 12 Months

2025. g. 27. aug. 22:52 UTC

Peļņas

South32 FY Underlying Ebitda $1.93 Billion, Up 7% On-Year

2025. g. 27. aug. 22:51 UTC

Peļņas

South32 FY Revenue $5.78 Billion, Up 17% On-Year

2025. g. 27. aug. 22:51 UTC

Peļņas

South32 FY Underlying Earnings $666 Million, Up 75% On-Year

2025. g. 27. aug. 22:50 UTC

Peļņas

South32 to Pay Final Dividend of 2.6 U.S. Cents/Share

2025. g. 27. aug. 22:50 UTC

Peļņas

South32 FY Net Profit $213 Million Vs $203 Million Loss Year Earlier

2025. g. 27. aug. 22:45 UTC

Peļņas

Sandfire Resources Expects FY26 Matsa Capital Expenditure of $148 Million

2025. g. 27. aug. 22:44 UTC

Peļņas

Sandfire Resources Expects FY26 Motheo Unit Cost of $44/Ton of Ore Processed

2025. g. 27. aug. 22:44 UTC

Peļņas

Sandfire Resources Expects FY26 Motheo Capital Expenditure of $82 Million

2025. g. 27. aug. 22:43 UTC

Peļņas

Sandfire Resources Expects FY26 Matsa Unit Cost of $86/Ton of Ore Processed

2025. g. 27. aug. 22:43 UTC

Peļņas

Nvidia Breaks Sales Record Despite Chinese Trade Hiccups -- 5th Update

2025. g. 27. aug. 22:42 UTC

Peļņas

Sandfire Resources Expects FY26 Motheo Copper Eq Output to Rise 3% to 61,000 Tons

2025. g. 27. aug. 22:42 UTC

Peļņas

Sandfire Resources Expects FY26 Matsa Copper Eq Output to Rise 2% to 96,000 Tons

2025. g. 27. aug. 22:40 UTC

Peļņas

Sandfire Resources Net Debt $123 Million at June 30

2025. g. 27. aug. 22:40 UTC

Peļņas

Sandfire Resources FY Underlying Ebitda $527.7 Million

Salīdzinājums

Cenas izmaiņa

DarioHealth Corp Prognoze

Cenas mērķis

By TipRanks

93.75% augšup

Prognoze 12 mēnešiem

Vidējais 0.93 USD  93.75%

Augstākais 1.25 USD

Zemākais 0.6 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi DarioHealth Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

1

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.6785 / 0.71Atbalsts un pretestība

Īstermiņā

Strong Bearish Evidence

Vidējā termiņā

Strong Bullish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par DarioHealth Corp

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.